Immunodeficiency, immunosuppression, and susceptibility to neoplasms.
Schwartz
R S
RS
New England Journal of Medicine, Boston, MA 02115, USA. rschwartz@nejm.org
D000328:Adult; D000818:Animals; D001402:B-Lymphocytes / Q000821:virology; D002648:Child; D004198:Disease Susceptibility; D020031:Epstein-Barr Virus Infections / Q000276:immunology; D030342:Genetic Diseases, Inborn / Q000150:complications / Q000276:immunology; D020022:Genetic Predisposition to Disease; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D006801:Humans; D016867:Immunocompromised Host; D007153:Immunologic Deficiency Syndromes / Q000150:complications* / Q000151:congenital / Q000235:genetics; D007157:Immunologic Surveillance; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007231:Infant, Newborn; D008232:Lymphoproliferative Disorders / Q000209:etiology / Q000821:virology; D051379:Mice; D018345:Mice, Knockout; D023421:Models, Animal; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology; D011183:Postoperative Complications / Q000209:etiology / Q000276:immunology; D014184:Transplantation, Homologous / Q000009:adverse effects / Q000276:immunology